Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSGN
676
DELISTED
MSG Networks Inc.
MSGN
| $15.6M | 0.03% |
+749,327
| New | +$15.2M |
|
|
SGYP
677
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $15.5M | 0.03% |
2,740,786
+50,927
| +2% | +$310K |
|
678
RPM International
RPM
$13.6B
| $15.5M | 0.03% |
352,666
+284,371
| +416% | +$12.8M |
|
679
ICU Medical
ICUI
$4.54B
| $15.5M | 0.03% |
137,500
-11,660
| -8% | -$1.29M |
|
680
Integra LifeSciences
IART
$1.29B
| $15.4M | 0.03% |
455,180
+239,224
| +111% | +$7.48M |
|
681
Hancock Whitney
HWC
$6.03B
| $15.4M | 0.03% |
612,083
+528,600
| +633% | +$14.4M |
|
|
SGMO
682
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $15.4M | 0.03% |
1,681,902
-673,667
| -29% | -$5.19M |
|
|
NVO
683
CALL
Novo Nordisk
NVO
$208B
| $15.3M | 0.03% |
+528,400
| New | +$14.6M |
|
684
Trimble
TRMB
$14.1B
| $15.3M | 0.03% |
714,133
+83,190
| +13% | +$1.73M |
|
685
Etsy
ETSY
$7.88B
| $15.3M | 0.03% |
+1,849,632
| New | +$18.8M |
|
|
LMNX
686
DELISTED
Luminex Corp
LMNX
| $15.3M | 0.03% |
713,920
-38,425
| -5% | -$774K |
|
687
Douglas Emmett
DEI
$2B
| $15.3M | 0.03% |
489,626
-1,415,648
| -74% | -$43.3M |
|
688
Leidos
LDOS
$17.4B
| $15.3M | 0.03% |
271,199
-124,685
| -31% | -$6.57M |
|
689
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $15.2M | 0.03% |
703,756
+465,000
| +195% | +$10.1M |
|
690
KB Home
KBH
$3.42B
| $15.2M | 0.03% |
1,233,979
-932,856
| -43% | -$12.6M |
|
691
Philips
PHG
$26.9B
| $15.2M | 0.03% |
833,343
+522,994
| +169% | +$9.79M |
|
692
Lennar Class A
LEN
$21.3B
| $15.2M | 0.03% |
325,672
-409,749
| -56% | -$19.5M |
|
|
TGP
693
DELISTED
Teekay LNG Partners L.P.
TGP
| $15.1M | 0.03% |
1,151,139
+913,798
| +385% | +$19.9M |
|
694
Equinix
EQIX
$103B
| $15.1M | 0.03% |
+49,996
| New | +$14.6M |
|
695
Apogee Enterprises
APOG
$863M
| $15.1M | 0.03% |
+347,207
| New | +$16.8M |
|
|
RXDX
696
DELISTED
Ignyta, Inc.
RXDX
| $15.1M | 0.03% |
1,124,798
-288,632
| -20% | -$3.48M |
|
697
Manhattan Associates
MANH
$12.4B
| $15M | 0.03% |
227,289
+130,034
| +134% | +$9.25M |
|
|
CERN
698
DELISTED
Cerner Corp
CERN
| $15M | 0.03% |
249,362
-121,348
| -33% | -$7.46M |
|
699
Plains All American Pipeline
PAA
$17.6B
| $15M | 0.03% |
649,465
+608,408
| +1,482% | +$16.4M |
|
700
The GEO Group
GEO
$4.24B
| $14.9M | 0.03% |
775,170
-127,295
| -14% | -$2.54M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.